Inspiolto package

Notice: Product images are for illustration purposes only and may differ from the medication you receive. Packaging and appearance may vary depending on the country of origin, and generic medications may be supplied by different manufacturers. The medication, strength, and active ingredients will match your prescription. At the Canadian Pharmacy Store we prioritize your health and safety by working with licensed pharmacy partners to provide safe, high-quality medications.

Inspiolto (Tiotropium Bromide Monohydrate / Olodaterol Hydrochloride)

Other Brands:Spiolto, Stiolto

Inspiolto Respimat

Tiotropium Bromide Monohydrate, Olodaterol Hydrochloride

Sourced from Canada Source: Canada
Prescription Required
Select product strength & quantity:

Stiolto Respimat

Tiotropium Bromide Monohydrate, Olodaterol Hydrochloride

Sourced from United Kingdom Source: United Kingdom
Prescription Required
Select product strength & quantity:
Select Strength & Quantity

Choose the strength, form, and package size that match your prescription.

Send Your Prescription

Upload your prescription online, request a transfer, or have your doctor fax us.

Pharmacist Review & Delivery

Reviewed by a licensed pharmacist and shipped to your U.S. address with tracking. Shipping details.

Description

Inspiolto (tiotropium bromide and olodaterol) is a respiratory medications and inhalers agent listed in our Respiratory medications and inhalers directory and prescribed for chronic obstructive pulmonary disease (1.1) (2.1). Administered via the respiratory (inhalation) route, Inspiolto is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.

Inspiolto is a medication containing the active pharmaceutical ingredient tiotropium bromide and olodaterol, classified pharmacologically as a respiratory medications and inhalers agent (2.1). It is clinically indicated for the management of chronic obstructive pulmonary disease as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).

Within the Respiratory medications and inhalers section of our catalogue, patients and prescribers frequently review Inspiolto alongside related therapies such as Spiolto (Tiotropium Bromide Monohydrate / Olodaterol Hydrochloride), Stiolto (Tiotropium Bromide Monohydrate / Olodaterol Hydrochloride), Acetylcysteine, and Advair Diskus (Fluticasone Propionate / Salmeterol Xinafoate).

Official Indications and Usage

Inspiolto is a combination of tiotropium bromide, an anticholinergic and olodaterol, a long-acting beta-2 adrenergic agonist (LABA) indicated for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Important limitations: Stiolto Respimat is not indicated to treat acute deterioration of COPD. (1.1)

Mechanism of Action and Pharmacology

Stiolto Respimat Stiolto Respimat contains both tiotropium and olodaterol. The properties described below for the individual components apply to Stiolto Respimat. These drugs represent 2 different classes of medication (an anticholinergic and a beta-agonist) that have different effects on clinical and physiological indices. Tiotropium Tiotropium is a long-acting, muscarinic antagonist which is often referred to as an anticholinergic. It has similar affinity to the subtypes of muscarinic receptors, M 1 to M 5. (1.1)

What is COPD?

Chronic obstructive pulmonary disease causes persistent breathing limitation. Treatment can include inhaled medicines, smoking cessation, rehabilitation, and an exacerbation plan. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete COPD condition guide for appointment questions and related therapies (2.1).

Ordering Inspiolto from Canada for U.S. Delivery

U.S. patients can order Inspiolto (Tiotropium, Olodaterol) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.

Step 1

Send Your Prescription

Step 2

Pharmacist Safety Check

  • Multi-point dosing and interaction review completed in under 1 business day.
  • Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
  • Verified under our Pharmacy Safety Standards.
Step 3

$14.99 USD Tracked Parcel

  • Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
  • Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
  • Review full shipping and delivery details.
Step 4

U.S. Street Delivery & Payment

  • Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
  • You see and approve the country of origin upfront before your card is charged.
  • Report any delayed or damaged parcel within 48 hours for prompt resolution.

Fact Table

Clinical Specification Details
Brand / Product Name Inspiolto
Chemical / Generic Name Tiotropium Bromide And Olodaterol
Pharmacological Class Respiratory medications and inhalers agent
Therapeutic Category Respiratory medications and inhalers
Molecular Weight 422.9 g/mol (2.1)
Bioavailability ~2% (1.1)
Protein Binding ~72% (1.1)
Elimination Half-Life ~25 hours (1.1)
Time to Peak Plasma Level (Tmax) 10 to 20 minutes (2.1)
Legal Status Rx-Only (Prescription Required)
Regulatory Reference Authorities U.S. FDA (DailyMed), Health Canada (DPD), NLM MedlinePlus
Routes of Administration Respiratory (Inhalation)
Dosage Forms & Strengths Inhalation spray: Each actuation from the mouthpiece delivers 2.5 mcg tiotropium (equivalent to 3.124 mcg tiotropium bromide monohydrate), and 2.5 mcg
Primary Indications Chronic Obstructive Pulmonary Disease
Pregnancy & Breastfeeding Consult Doctor / Prescriber before use
FDA UNII Identifier L64SXO195N, 65R445W3V9
NLM RxNorm Concept ID (RxCUI) 1651266, 1651271, 1651274, 1651275
FDA Application License NDA206756
Official DailyMed SetID 01e15aee-40e0-23f3-537f-c96dd63e2cb1
Catalogue Index Links Letter I Index · All Medications · All Categories

Directions

Dosage and Administration Overview

For oral inhalation only. Two inhalations of Stiolto Respimat once-daily at the same time of day. (1.1)

Presentations and Strengths

Inhalation spray: Each actuation from the mouthpiece delivers 2.5 mcg tiotropium (equivalent to 3.124 mcg tiotropium bromide monohydrate), and 2.5 mcg olodaterol (equivalent to 2.736 mcg olodaterol hydrochloride). Two actuations equal one dose. Inhalation Spray: Stiolto Respimat consists of a Stiolto Respimat inhaler and an aluminum cylinder (Stiolto Respimat cartridge) containing a combination of tiotropium bromide (as the monohydrate) and olodaterol (as the hydrochloride). The Stiolto Respimat cartridge is intended only for use with the Stiolto Respimat inhaler. (1.1)

Administration Guidance

Administer Inspiolto strictly via the prescribed inhalation device according to the schedule set by your healthcare provider (1.1). Prime, load, inhale, and clean the inhaler exactly as shown in the manufacturer’s patient leaflet. If using an inhaled corticosteroid preparation, rinse your mouth with water and spit out after each dose when directed to reduce local throat irritation.

Missed Dose Guidance

If you miss a scheduled dose of Inspiolto, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).

Ingredients

Active Pharmaceutical Ingredient

The active ingredient in Inspiolto is tiotropium bromide and olodaterol (2.1).

Excipients and Formulation Carriers

Film coatings, stabilizers, and inactive carriers vary by strength and manufacturer presentation. If you have a known allergy to lactose, dyes, sulfites, or specific preservatives, ask our pharmacist to check the exact excipient list for your selected package (2.1).

Cautions and important safety information

Contraindications

Use of a LABA, including Stiolto Respimat, without an inhaled corticosteroid is contraindicated in patients with asthma. Stiolto Respimat is not indicated for the treatment of asthma. Stiolto Respimat is contraindicated in patients with a hypersensitivity to tiotropium, ipratropium, olodaterol, or any component of this product. In clinical trials and postmarketing experience with tiotropium, immediate hypersensitivity reactions, including angioedema (including swelling of the lips, tongue, or throat), itching, or rash have been reported. Hypersensitivity reactions were also reported in clinical trials with Stiolto Respimat. (1.1)

Key Clinical Precautions

Before starting or continuing Inspiolto, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):

  • Diabetic ketoacidosis (DKA): Ketoacidosis, a serious condition requiring urgent hospitalization, has been reported even when blood glucose readings are below 250 mg/dL. Risk factors include acute febrile illness, reduced caloric or fluid intake, pancreatic disorders, surgery, and insulin dose reduction.
  • Hypersensitivity and anaphylaxis: Serious allergic reactions, including anaphylaxis, angioedema, and severe rash, have been reported. Discontinue use and seek immediate medical care if swelling of the face, lips, tongue, or throat or difficulty breathing occurs.
  • Angioedema: Swelling of the face, extremities, lips, tongue, glottis, or larynx can occur at any time during treatment. Airway-involving angioedema requires emergency medical intervention.
  • Blood pressure elevation: Monitor blood pressure regularly during treatment and inform your clinician if sustained increases occur.

Pregnancy, Lactation, and Special Populations

There are no adequate and well-controlled clinical studies with Stiolto Respimat or its individual components, tiotropium bromide and olodaterol, in pregnant women to inform of drug-associated risk of adverse pregnancy-related outcomes. Animal reproduction studies were conducted with the individual components of Stiolto Respimat, tiotropium bromide and olodaterol. There are clinical considerations with the use of Stiolto Respimat in pregnant women. Stiolto Respimat should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. (1.1)

Interactions

Official Drug Interaction Overview

Other adrenergic drugs may potentiate effect. Use with caution. Xanthine derivatives, steroids, diuretics, or non-potassium sparing diuretics may potentiate hypokalemia or ECG changes. Mao inhibitors, tricyclic antidepressants, and drugs that prolong QTc interval may potentiate effect on cardiovascular system. Use with extreme caution. (1.1)

Important Interaction Categories

Concomitant use of Inspiolto with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):

  • Potassium supplements, potassium-sparing diuretics (such as Aldactone (Spironolactone), eplerenone, triamterene, or amiloride), and salt substitutes: Concomitant use can lead to clinically significant hyperkalemia (elevated serum potassium). Regular electrolyte monitoring is recommended.
  • Monoamine oxidase inhibitors (MAOIs, such as phenelzine, tranylcypromine, selegiline, or linezolid): Concomitant use or use within 14 days of stopping an MAOI can cause severe drug interactions, including hypertensive crisis, serotonin syndrome, or enhanced hypoglycemic and central nervous system effects.

Side effects

Like all medications, Inspiolto can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):

  • Constipation: Adequate hydration and dietary fiber can help manage mild changes in bowel habits.
  • Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
  • Insomnia or sleep disturbances: Taking morning doses earlier in the day (if consistent with your prescription) may reduce nighttime restlessness.
  • Xerostomia (dry mouth): Sipping water or using sugar-free lozenges can help relieve oral dryness.
  • Skin rash: Mild skin eruptions can occur; seek immediate care if a rash blisters, peels, or is accompanied by fever.
  • Pruritus (mild itching): Report any spreading rash, hives, or mucosal irritation to your healthcare provider.

Clinical Trial and Postmarketing Adverse Reactions

LABA, such as olodaterol, one of the active components in Stiolto Respimat, as monotherapy (without an inhaled corticosteroid) for asthma, increase the risk of asthma-related events. Stiolto Respimat is not indicated for the treatment of asthma. The following adverse reactions are described, or described in greater detail, in other sections: Immediate hypersensitivity reactions Paradoxical bronchospasm Worsening of narrow-angle glaucoma Worsening of urinary retention The most common adverse reactions (>3% incidence and more than an active control) were nasopharyngitis, cough, and back pain. (1.1)

When to Seek Immediate Medical Attention

Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).

Storage and handling

Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Avoid freezing. (1.1)

Store Inspiolto in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).

Frequently Asked Questions About Inspiolto

What is Inspiolto and what active ingredient does it contain?

Inspiolto is a respiratory medications and inhalers agent containing the active pharmaceutical ingredient tiotropium bromide and olodaterol. It is supplied for respiratory (inhalation) administration and requires a valid prescription where applicable.

How does Inspiolto work in the body?

Stiolto Respimat Stiolto Respimat contains both tiotropium and olodaterol. The properties described below for the individual components apply to Stiolto Respimat. These drugs represent 2 different classes of medication (an anticholinergic and a beta-agonist) that have different effects on clinical and physiological indices.

What conditions is Inspiolto prescribed to treat?

Inspiolto is primarily indicated for chronic obstructive pulmonary disease. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.

How should I take or use Inspiolto?

Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Inspiolto is administered via the respiratory (inhalation) route. Inhale or administer it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.

What are the most common side effects of Inspiolto?

Commonly reported side effects of Inspiolto include constipation, dizziness, difficulty sleeping, dry mouth, rash, and itching. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.

What medications or substances can interact with Inspiolto?

Important interaction categories for Inspiolto include potassium-containing products and monoamine oxidase inhibitors. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.

Can Inspiolto be used during pregnancy or breastfeeding?

If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Inspiolto to weigh the clinical benefits and potential risks.

Do I need a prescription to buy Inspiolto online from Canada?

Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Inspiolto (Tiotropium, Olodaterol) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).

Does Inspiolto have a generic equivalent (Tiotropium, Olodaterol) at a Canada pharmacy?

Currently, Inspiolto (Tiotropium, Olodaterol) is dispensed in our catalogue as a brand-name formulation. Check our Tiotropium, Olodaterol active ingredient hub for updates as licensed generic presentations become available.

How is Inspiolto shipped to U.S. residents, and how much does shipping cost?

Inspiolto ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.

How can I send or transfer my Inspiolto prescription, or ask about an unlisted strength?

You can upload a clear photo or PDF of your Inspiolto prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.

References & Official Sources

Clinical, pharmacological, and safety facts for Inspiolto (Tiotropium Bromide Monohydrate / Olodaterol Hydrochloride) are compiled directly from official regulatory prescribing labels and primary biomedical databases:

  1. (1.1) Stiolto Respimat. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
  2. (2.1) MedlinePlus Medical Encyclopedia: COPD. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
  3. (3.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).

Related Condition Guides

Related Guides

Call 1-888-868-1920Help